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Abstract 
 
Purpose: To investigate the role of sex on the symptomatology of DED and on the 
associations between symptoms and signs. 
Methods:  A cross-sectional study was used including 755 dry eye patients from the 
Groningen Longitudinal Sicca Study (GLOSSY cohort). Patient symptoms were assessed by 
the Ocular Surface Disease Index (OSDI) questionnaire and dry eye signs by the six most 
commonly used tests. Patients were divided in groups based on overall severity of signs and 
within these groups total and specific symptoms were compared by sex. Sex differences in 
Spearman correlation between symptoms and signs were calculated. 
Results:  Women had higher total symptom scores than men in both the mild (33.8 vs 24.7, 
P=0.01) and moderate signs groups (38.3 vs 28.0, P<0.005), but this difference was less 
apparent in the severe signs group (40.4 vs 37.2, P=0.33). Independent of severity of signs, 
women consistently reported more light sensitivity than men (P<0.01 in all groups). The 
correlation between symptoms and overall severity of signs score was significantly lower in 
women (ρ =0.11 vs ρ =0.33 in men, P=0.01), with clearest differences between women and 
men in correlations with Schirmer (ρ= 0.01 vs ρ =-0.21, P=0.03) and TFBUT (ρ =-0.08 vs ρ 
=-0.30, P=0.02). 
Conclusions: This large clinical study has shown that sex has a large influence on the 
symptomatology of DED, with significantly higher symptom scores and lower correlation 
between symptoms and signs in women compared to men. These findings are of importance 
in clinical practice and in conducting research into DED. 
 
Key words: dry eye disease; epidemiology; gender; neuropathic dry eye; sex; signs; 
symptoms.  
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1. Introduction 
 
The importance of sex and gender disparities and the need to account for sex as a biological 
variable is being increasingly emphasized in medical research.1 In Ophthalmology there are 
notable sex differences in many traits and diseases, but very little is known about root causes 
to enable design and implementation of diagnostic, preventive and treatment strategies.2 Dry 
eye disease (DED) is no exception, as numerous epidemiological studies have shown that 
DED is far more prevalent in women than in men and biological studies have shown that sex 
has a major influence on the regulation of the ocular surface and adnexa.3, 4 Different 
underlying mechanisms of pathophysiology have been proposed, such as a possible important 
role for sex steroids and other hormone imbalances in women.4 However, despite all the 
epidemiological and biological studies, there is still a surprisingly lack of knowledge about 
the influence of sex in clinical characteristics of DED. To our knowledge, only one study has 
reported sex differences in total symptoms of DED, showing more symptoms in women.5 
However, there have been no reported studies investigating sex differences in clinical 
characteristics of DED, including both symptoms and signs and their correlation. Indeed, the 
recently published TFOS DEWS II report on Sex, gender and hormones4 advocated the need 
for further studies to clarify the precise nature and extent of sex and gender effects on DED, 
with a special need for epidemiological studies using data on both signs and symptoms, and 
for studies investigating differences in diagnostic tests between men and women. Therefore, 
this study aimed to explore the role of sex in the clinical characteristics of dry eye patients, 
using a large tertiary dry eye patient cohort. We investigated sex differences in both the 
symptomatology of DED and the association between DED symptoms and the most 
commonly tested signs in clinic. 
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2.Methods 
  
2.1 Study sample 
The GLOSSY (Groningen LOngitudinal Sicca StudY) cohort is a clinic-based cohort of dry 
eye patients from the tertiary dry eye clinic at the University Medical Center Groningen in the 
Netherlands. General and ophthalmic medical history, dry eye symptoms, dry eye test results 
using standardized methods, and dry eye therapies have been recorded longitudinally since 
September 2014, resulting in a clinical cohort with data on approximately 1500 patient visits a 
year. The University Medical Center Groningen is a national referral center for Sjögren 
syndrome, and consequently, almost half of the patients visiting the tertiary dry eye clinic are 
Sjögren patients. All patients recruited to the GLOSSY cohort until December 2016 were 
included in this study. These patients have either dry eye diagnosed by an ophthalmologist 
and/or are under the care of the multidisciplinary Sjögren syndrome service. No further 
exclusion criteria were applied. The study was approved by the Institutional Review Board 
(IRB) of the University Medical Center Groningen. The research followed the tenets of the 
Declaration of Helsinki. Information on sex was derived from the patient’s passport, which 
represents biological sex. To our knowledge, there were no transsexuals in our cohort.  
 
2.2 Assessment of dry eye symptoms 
All patients completed the Ocular Surface Disease Index (OSDI) at the beginning of their 
visit. The OSDI, developed by the Outcomes Research Group at Allergan Inc (Irvine, 
California), is a 12-item questionnaire designed to provide a rapid assessment of the 
symptoms of ocular irritation consistent with dry eye disease and their impact on vision-
related functioning.6 Presence of symptoms during the last week is rated per item on a five-
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point scale (0-4) from 'none of the time' to 'all of the time'. The OSDI total score (ranging 
from 0-100) can be calculated with a formula that uses the sum score of all completed 
questions. In a similar way, scores from the 3 OSDI subscales (i) ocular symptoms, (ii) 
vision-related functions, and (iii) environmental triggers can be calculated by looking at 
questions 1-5, 6-9 and 10-12, respectively.6 
 
2.3 Assessment of dry eye signs 
Dry eye tests were performed in both eyes, in the following order: tear osmolarity, Schirmer 
test without anaesthesia, staining of the cornea with fluorescein, tear fluorescein breakup time 
(TFBUT), staining of the nasal and temporal conjunctiva with lissamine green, and 
Meibomian gland dysfunction. Ophthalmologists that graded the dry eye were not aware of 
the study question.  Tear osmolarity was measured from the inferior lateral meniscus with a 
laboratory-on-a-chip by the TearLab Osmolarity System (San Diego, Ca) following standard 
protocols.7 An unanaesthetized Schirmer-1 value after 5 minutes (mm/5 min) using sterile 
strips was measured following standard protocols.7 Staining of the cornea with fluorescein 
was performed using the Oxford Schema grading, ranging from grade 0 to 5, based on the 
number of punctate dots for the total exposed inter-palpebral cornea.7 Staining of the 
conjunctiva with lissamine green was performed in a similar way using the Oxford Schema 
grading, scoring both the temporal and nasal zone and taking the sum of these scores per eye, 
ranging from 0 to 10.7 TFBUT was measured by instilling a drop of fluorescein counting the 
seconds after a blink before the tear film was broken up, following standard protocols.7 The 
median score of three measurements per eye was taken. Meibomian gland dysfunction was 
scored by taking the average of the quality score (0 clear; 1 cloudy; 2 granular; 3 toothpaste) 
and the expressibility score (0 minimal; 1 light; 2 moderate; 3 heavy pressure needed) of the 
meibum.8 Each of the 6 dry eye tests was transformed to a common unit severity score 
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between 0 and 1, with 0 being no sign of DED at all and 1 being the highest severity grade of 
DED for that test. Subsequently, an overall severity of signs score was calculated for each 
patient by taking the mean severity score of these 6 tests. For more information on how this 
score was exactly calculated see Vehof et al.9  
 
2.4 Statistical analysis 
First, descriptive statistics were used to describe the characteristics of the study population, 
stratified by sex. Patients were divided into three groups based on the patient’s overall 
severity of signs score: mild (0-0.24), moderate (0.25-0.49) and severe signs (0.5-1.0), to 
reflect the dry eye severity grading scheme proposed by DEWS as closely as possible.10 Then, 
within groups total OSDI symptom scores and specific symptom scores were compared 
between men and women, using Mann-Whitney U-tests. Subsequently, Spearman correlations 
between total OSDI symptom score and signs were calculated, stratified by sex. Differences 
in correlations between sex were tested for statistical significance by using Fisher’s r-to-z 
transformation for correlation coefficients in independent samples, testing the null hypothesis 
that ρ1-ρ2=0.11 Data were analyzed with the SPSS statistical package (version 23.0; SPSS, 
Inc). A P-value lower than 0.05 was considered statistically significant in all analyses. 
3. Results  
The first consecutive 755 DED patients from the GLOSSY cohort were included. The 
majority was female (n=607, 80.4%) and the mean age was 56.1 (standard deviation 15.7) 
years. Table 1 shows the demographics and the prevalence of self-reported comorbidities, 
stratified by sex. The prevalence of chronic pain syndromes, Sjögren syndrome, osteoarthritis, 
the presence of any allergy, and thyroid disease were all higher in women, consistent with 
distribution of these diseases in the general population. Men had a significantly higher use of 
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beta-blockers and higher prevalence of graft-versus-host disease. Table 2 shows the mean 
signs and symptoms stratified by sex. Women, on average, had higher total symptoms score, 
but also higher tear osmolarity, higher corneal and conjunctival staining scores, and lower 
TFBUT. Schirmer scores and Meibomian gland dysfunction did not significantly differ 
between groups. Women were consequently more frequently categorized in the groups with 
higher overall severity of signs scores. However, within each of these three groups the 
severity of signs scores were not significantly different between men and women, indicating 
an equal level of signs in men and women within the mild, moderate and severe signs groups. 
 
Figure 1 shows the total OSDI symptoms scores, stratified by overall severity of signs and 
sex. In the mild and moderate signs groups, women had significantly higher total symptom 
scores than men (being around 40% higher score in women in both groups). This difference 
was however not as apparent in the severe signs group, where men and women had more 
similar total symptom scores (around 8% higher in women, P=0.33). Looking at the specific 
symptoms from the OSDI (Figure 2), within the mild and moderate signs groups women had 
higher scores than men on particularly light sensitivity and an uncomfortable feeling in windy 
conditions, low humidity and air conditioned areas. In the severe signs group there were no 
clear sex differences in specific symptoms, with the exception of only light sensitivity, again 
reported significantly more by women than by men, suggesting it is a female-specific 
symptom independent of severity of signs.  
 
In Figure 3 the correlations between DED signs and total symptoms score are presented for 
the total sample. The correlation coefficient of symptoms with overall signs severity score 
was only 0.11 (P=0.009) in women and a higher 0.33 (P<0.0005) in men (P-value for a 
difference = 0.01) indicating that, in general, women show significantly lower correlation 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9
between symptoms and signs. Largest sex differences in correlations between symptoms and 
specific signs were found with Schirmer value (women ρ =0.01 (P=0.84) versus men ρ =-0.21 
(P=0.02), P-value for a difference =0.03), and TFBUT (women ρ =-0.08 (P=0.06) versus men 
ρ =-0.30 (P=0.001), P-value for a difference =0.02). Sex differences in correlation between 
symptoms and overall sign severity score were visible in all signs severity groups, but most 
pronounced in the severe signs group: mild signs women ρ=0.15 (P=0.13), men ρ=0.28 
(P=0.06); moderate signs women ρ=0.07 (P=0.28), men ρ=0.22 (P=0.10); severe signs women 
ρ=0.02 (P=0.82), men ρ=0.47 (P=0.001). 
 
4. Discussion 
 
To our knowledge, this study is the first clinical study specifically looking at sex differences 
in clinical characteristics of DED patients. Our results showed that, even when corrected for 
severity of signs, female dry eye patients tend to be more symptomatic than men, especially 
when only mild or moderate signs are present. An uncomfortable feeling with environmental 
triggers like wind and air-conditioning, and particularly light sensitivity are symptoms that 
were identified as female specific symptoms. Perhaps most intriguing, women showed 
significantly lower correlations between symptoms and signs. These results are important to 
realize in clinical practice and critical in designing or analyzing studies, where subgroup 
analyses or stratification seems to be inevitable 
 
The finding of increased dry eye symptoms even with similar severity of clinical signs and the 
lack of association of symptoms with signs in women compared to men could be the result of 
several underlying mechanisms. First, there might be sex differences in the sensitivity of the 
ocular surface. Several studies, in differing settings, showed at least some evidence of 
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increased corneal or conjunctival sensitivity in women, although this sex difference might 
depend on factors such as pre- or postmenopausal status, and might vary between mechanical, 
chemical and thermal sensitivity.12-16 Other studies however did not find any sex difference in 
corneal sensitivity.17, 18 Future studies are needed to confirm and further explore these 
differences, but also to clarify the exact role of ocular surface sensitivity in the 
symptomatology of DED. 
 
Second, sex differences in general pain sensitivity might play a role. There is extensive 
literature on this topic, and it has been shown that the female sex is an important risk factor 
for many clinical pain conditions, including chronic pain syndromes, widespread pain, and 
neuropathic pain.19 A literature review of sex differences in experimental pain perception 
concluded that women had a consistently lower pain tolerance for cold pain, hot pain and 
pressure pain.20 Our group has shown in a large sample of female volunteers that dry eye 
symptoms were associated with both higher pain sensitivity and lower pain tolerance, as 
tested by a heat stimulus on the forearm, indicating the link between dry eye symptoms and 
general pain sensitivity.21 In an extended sample of this twin cohort we have shown that the 
chronic pain syndromes irritable bowel syndrome, fibromyalgia and pelvic pain show shared 
genetic factors with DED, indicating that DED is, at least partly, part of a spectrum of chronic 
pain disorders.22 So, given all these findings together, it might not be surprising that the 
present study found women to have lower correlation between symptoms and signs. That dry 
eye involves more than the ocular surface alone is increasingly recognized. In the recently 
published TFOS DEWS II Definition and Classification Report23 neuropathic dry eye was 
added in the classification scheme of dry eye, in addition to the well-recognized evaporative 
and aqueous deficient dry eye. In the present study women particularly reported increased 
light sensitivity and an uncomfortable feeling due to environmental triggers such as air 
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conditioning and wind. Interestingly, exactly these symptoms have been linked to ocular 
neuropathic pain in other studies.24, 25 So, the more frequent report of these specific symptoms 
and the lower correlation between symptoms and signs in women, might all point to an 
increased frequency of neuropathic dry eye in women as compared to men. 
 
Third, the role of gender might also be an important factor explaining our results. Where sex 
refers to the anatomy of an individual’s reproductive system and functions that derive from 
the chromosomal complement, gender refers to a person’s self-representation as male or 
female or how that person is responded to by social institutions on the basis of the 
individual’s gender presentation.26 As the feminine gender role is generally associated with a 
greater willingness to report pain4, this might be another cause of increased OSDI scores in 
our female patients. 
 
Fourth, women are more at risk for the majority of comorbidities that are risk factors of DED3, 
4, 27
, such as allergies, chronic pain syndromes, depression, anxiety, and autoimmune diseases 
such as Sjögren syndrome. This is also reflected in our sample (see Table 1). Difference in 
distribution of underlying etiologies could also lead to altered symptomatology between men 
and women. For example, non ocular studies have shown that depression and pain are highly 
comorbid and that depression can lead to increased pain.19 Moreover, in persons with a 
depression, women are more likely to report pain complaints than men.28 On top of that, in a 
study looking at the discordance between symptoms and signs in DED we have shown that 
the presence of chronic pain syndromes, allergies and depression are all associated with 
relatively more symptoms than signs.9 However, the presence of Sjögren syndrome was 
associated with the opposite.  
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In addition, the more diffuse group of etiologies in female dry eye patients might also 
mathematically have a major influence on the correlation between symptoms and signs. A 
hypothetical illustration of this is given in Table 3: combining two subgroups of dry eye 
patients, each with a perfect correlation between symptoms and signs, can result in a very low 
correlation of almost zero if the subgroups differ greatly in mean symptoms and/or sign 
scores. This difference in mean signs and/or symptoms between subgroups could easily be the 
case in dry eye, where for example patients with chronic pain syndromes have higher 
symptom scores without accompanying worse clinical signs29 and Sjögren patients have 
similar symptoms despite higher sign scores compared to other patients30. The example in 
Table 3 also may, in part, supply an explanation for the well-known lack of correlation 
between signs and symptoms in DED: unless a ‘pure’ group of DED patients including only 
one underlying etiology is studied, correlations may be low. So, given the multifactorial 
pathophysiology of DED and our current findings, stratification on subgroups based on sex 
and/or underlying aetiology in studies might be more important than we realize.  
 
To our knowledge, ours is the first study to take into account the severity of signs, but we are 
not the first to report greater symptoms in women; Schaumberg et al investigated sex 
differences in symptoms in 581 men and 1518 women with self-reported diagnosis of dry eye, 
using a questionnaire that included the OSDI.5 They found significantly higher symptoms in 
female than in male dry eye patients (total OSDI score of 29.0 vs 18.5, P<0.0001), which was 
present across all 3 subscales of the OSDI, similarly with the highest difference in the 
environmental triggers subscale. Compared to their patient cohort, our patients had a total 
OSDI score that is around 10 points higher in both men and women, which reflects the 
severity of patients in our tertiary dry eye clinic compared to a questionnaire based self-report 
of a dry eye diagnosis. Schaumberg et al did however not test for dry eye signs, and results 
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must be interpreted with caution as men and women were selected from different populations, 
with differences in education level and age of inclusion, which could have confounded results. 
 
Our findings reflect our cohort from a tertiary dry eye clinic with a relatively large group of 
Sjögren patients. This might limit the generalizability to other DED patient cohorts. However, 
as a crude sensitivity analysis, we found similar sex differences in correlation between overall 
signs severity score and symptoms in non-Sjögren patients (women ρ=0.12, men ρ =0.30) as 
in primary (women ρ =0.18, men ρ =0.31) and secondary (women ρ =0.13, men ρ =0.28) 
Sjögren dry eye patients. Although we included the most commonly tested signs in our study, 
another limitation might be that symptoms in female dry eye patients are better captured by 
other tests. We recommend further research in this area. A strength of this study is the large 
sample size of the GLOSSY cohort and the systematic assessment of the dry eye tests, using 
standardized protocols, that were all performed in one center. Our study has the required large 
sample size with sufficient power to detect a difference in correlation coefficients between 
men and women.  
 
In conclusion, this study found that sex has an important effect on the clinical characteristics 
of DED. This finding has important consequences for the interpretation of outcomes in both 
clinical practice and clinical studies, and further studies are needed to find out how to best 
address this in the diagnostics and treatment of DED. DED studies, like most studies in 
medicine, rarely stratify on sex, and our findings clearly underline the importance of this.  
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Figure 1: Sex differences in total dry eye symptoms, stratified by overall severity of signs 
(total n=755).  
Error bars represent 95% confidence intervals. 
 
Figure 2: Sex differences in specific dry eye symptoms, stratified by overall severity of signs: 
a) mild dry eye signs, b) moderate dry eye signs, and c) severe dry eye signs. 
Error bars represent 95% confidence intervals. 
 
Figure 3: Sex differences in the correlation between dry eye signs and symptoms. 
 
MGD = Meibomian Gland Dysfunction. TFBUT = Tear Fluorescein Breakup Time. 
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Table 1: Demographics and comorbidities of dry eye disease patients, stratified by sex. 
 
Men  
(n=148) 
Women  
(n=607) 
P-value for a 
difference 
Age (yrs) (mean, sd) 55.0 (15.5) 56.4 (15.8) 0.47 
Self reported 
comorbidity / use of  
medication (%): 
  
 
Depression 7 7 0.73 
Chronic pain syndrome 6 21 <0.0005 
Chronic fatigue 
syndrome 2 4 0.37 
Diabetes 6 5 0.46 
Osteoarthritis 5 20 <0.0005 
Rheumatoid Arthritis 16 20 0.1 
GVHD 10 2 <0.0005 
Thyroid disease 7 16 0.001 
Sjögren syndrome 22 51 <0.0005 
Allergy (any) 7 18 0.008 
Asthma 10 12 0.41 
Hayfever 8 14 0.3 
Eczema 11 13 0.36 
Contact lens user 3 3 1.00 
Postmenopausal n/a 65 n/a 
Use of betablockers 25 16 0.009 
Use of antidepressants 7 8 0.36 
Use of antihistamines 3 9 0.04 
Use of diuretics 11 12 0.79 
 
N/a: not applicable. Sd: standard deviation. GVHD: Graft-versus-host disease. 
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Table 2: Mean symptoms and signs of dry eye disease patients, stratified by sex.  
 
Men  
(n=148) 
Women  
(n=607) 
P-value for a 
difference 
Total OSDI symptom score 29.9 (23.9) 38.3 (24.3) <0.0005 
Ocular symptoms subscale 29.8 (24.4) 37.2 (24.1) <0.0005 
Vision related function subscale 27.0 (28.7) 31.7 (28.3) 0.22 
Environmental triggers subscale 38.6 (33.1) 51.4 (33.5) <0.0005 
Overall signs severity score 
 
0.34 (0.20) 
 
0.39 (0.19) 0.004 
Corneal staining (Oxford, 0-5) 1.41 (1.43) 1.62 (1.36) 0.048 
Conjunctival staining (Oxford, 0-10) 2.15 (2.38) 2.79 (2.75) 0.027 
Schirmer (mm/5 mins) 6.80 (13.3) 6.60 (16.8) 0.31 
TFBUT (s) 5.4 (3.7) 4.4 (3.2) 0.01 
Tear osmolarity (mOsm/l) 309.5 (17.5) 316.0 (19.4) 0.004 
MGD score (0-3) 0.98 (0.90) 0.90 (0.87) 0.31 
Signs severity group 
  
0.01 
Mild 44 (29.8%) 110 (18.1%)  
Overall signs severity score 
within mild signs group 0.12 (0.05) 0.13 (0.06) 0.28 
Moderate 57 (38.5%) 249 (41.0%)  
Overall signs severity score 
within moderate signs group 0.33 (0.09) 0.32 (0.08) 0.18 
Severe 47 (31.8%) 248 (40.9%)  
Overall signs severity score 
within severe signs group 0.56 (0.12) 0.57 (0.12) 0.56 
Mean (standard deviation) or n (%) are given. OSDI = Ocular Surface Disease Index. TFBUT= Tear 
fluorescein breakup time. MGD = Meibomian gland dysfunction.  
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 3: Hypothetical illustration of how combining subgroups of dry eye patients could lead to a 
dramatic fall in correlation coefficient between symptoms and signs. 
Dry eye patients with 
Sjögren syndrome 
(n=10) 
Dry eye patients with 
chronic pain syndrome 
(n=10) 
Combined Sjögren 
syndrome and chronic 
pain syndrome dry eye 
patients (n=20) 
Sign score 
Symptom 
score Sign score 
Symptom 
score Sign score 
Sympto
m score 
2 1 1 7 2 1 
4 2 2 9 4 2 
6 3 3 11 6 3 
8 4 4 13 8 4 
10 5 5 15 10 5 
12 6 6 17 12 6 
14 7 7 19 14 7 
16 8 8 21 16 8 
18 9 9 23 18 9 
20 10 10 25 20 10 
Correlation: 1.00 Correlation: 1.00 1 7 
 
2 9 
3 11 
4 13 
5 15 
6 17 
7 19 
8 21 
9 23 
10 25 
Correlation: 0.06 
 
In this illustration, dry eye patients with Sjögren syndrome and chronic pain syndromes both show a 
perfect correlation of 1.00 between symptom and sign scores. Because Sjögren patients tend to have 
relatively more signs than symptoms, and chronic pain syndrome patients tend to have relatively more 
symptoms than signs, the correlation between symptoms and signs drops dramatically to 0.06 if the two 
groups are combined.   
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